Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years.
Ensslin C, Micheroli R, Kissling S, Götschi A, Bürki K, Bräm R, de Hooge M, Baraliakos X, Nissen MJ, Möller B, Exer P, Andor M, Distler O, Scherer A, Ciurea A. Ensslin C, et al. Among authors: ciurea a. RMD Open. 2023 Jul;9(3):e003340. doi: 10.1136/rmdopen-2023-003340. RMD Open. 2023. PMID: 37507208 Free PMC article.
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Finckh A, et al. Among authors: ciurea a. Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520. Arthritis Rheum. 2007. PMID: 17469098 Free article.
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Ciurea A, et al. Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140. Arthritis Rheum. 2013. PMID: 23983141 Free article.
Age at symptom onset in ankylosing spondylitis: is there a gender difference?
Ciurea A, Scherer A, Weber U, Neuenschwander R, Tamborrini G, Exer P, Bernhard J, Villiger PM, Kissling R, Michel BA, Stekhoven D; rheumatologists of the Swiss Clinical Quality Management Program for axial spondyloarthritis. Ciurea A, et al. Ann Rheum Dis. 2014 Oct;73(10):1908-10. doi: 10.1136/annrheumdis-2014-205613. Epub 2014 Aug 7. Ann Rheum Dis. 2014. PMID: 25104774 No abstract available.
Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
Ciurea A, Weber U, Stekhoven D, Scherer A, Tamborrini G, Bernhard J, Toniolo M, Villiger PM, Zufferey P, Kissling RO, Michel BA, Exer P; Rheumatologists of Swiss Clinical Quality Management. Ciurea A, et al. J Rheumatol. 2015 Jan;42(1):101-5. doi: 10.3899/jrheum.140229. Epub 2014 Nov 1. J Rheumatol. 2015. PMID: 25362654
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.
Ciurea A, Scherer A, Weber U, Exer P, Bernhard J, Tamborrini G, Riek M, Müller RB, Weiss B, Nissen MJ, Kissling R, Michel BA, Finckh A; Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Ciurea A, et al. Ann Rheum Dis. 2016 Mar;75(3):532-9. doi: 10.1136/annrheumdis-2013-205133. Epub 2015 Feb 9. Ann Rheum Dis. 2016. PMID: 25667205
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.
Ciurea A, Exer P, Weber U, Tamborrini G, Steininger B, Kissling RO, Bernhard J, Scherer A; Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Ciurea A, et al. Arthritis Res Ther. 2016 Mar 22;18:71. doi: 10.1186/s13075-016-0969-2. Arthritis Res Ther. 2016. PMID: 27000865 Free PMC article.
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis.
Nissen MJ, Ciurea A, Bernhard J, Tamborrini G, Mueller R, Weiss B, Toniolo M, Exer P, Gabay C, Finckh A; physicians of the Swiss Clinical Quality Management Cohort. Nissen MJ, et al. Among authors: ciurea a. Arthritis Rheumatol. 2016 Sep;68(9):2141-50. doi: 10.1002/art.39691. Arthritis Rheumatol. 2016. PMID: 27015429 Free article.
344 results